- Biogen’s Alzheimer’s drug slows cognitive decline in early study STAT
- More convenient form of breakthrough Alzheimer’s drug Leqembi shows promising results in study CNBC
- New studies find benefits in very early drug treatment of Alzheimer’s Financial Times
- New Data from Biogen’s Investigational Antisense Oligonucleotide (ASO) Targeting Tau Shows Promise for Potential New Generation of Treatments in Early Alzheimer’s Disease | Biogen Biogen
- Alzheimer’s drug Leqembi could be given as shots rather than IV infusion, study suggests CNN
- View Full Coverage on Google News
Tag Archives: Biogens
New Data from Biogen’s Investigational Antisense Oligonucleotide (ASO) Targeting Tau Shows Promise for Potential New Generation of Treatments in Early Alzheimer’s Disease | Biogen – Biogen
- New Data from Biogen’s Investigational Antisense Oligonucleotide (ASO) Targeting Tau Shows Promise for Potential New Generation of Treatments in Early Alzheimer’s Disease | Biogen Biogen
- More convenient form of breakthrough Alzheimer’s drug Leqembi shows promising results in study CNBC
- Biogen’s Alzheimer’s drug slows cognitive decline in early study STAT
- Biogen, Eli Lilly present new clinical data in race to field Alzheimer’s treatments The Boston Globe
- Alzheimer’s drug Leqembi could be given as shots rather than IV infusion, study suggests CNN
- View Full Coverage on Google News
FDA advisors vote against effectiveness of Biogen’s ALS drug for rare and aggressive form of the disease – CNBC
- FDA advisors vote against effectiveness of Biogen’s ALS drug for rare and aggressive form of the disease CNBC
- Biogen ALS drug considered not effective by FDA advisory panel MarketWatch
- FDA advisory panel recommends conditional approval of Biogen’s drug for rare form of ALS STAT
- FDA advisors reject Biogen’s ALS drug for rare and aggressive form of the disease CNBC
- Shares of tech companies are trading lower amid overall market volatility after the Fed raised rates by 25 basis point. – NetApp (NASDAQ:NTAP), Zoom Video Comms (NASDAQ:ZM), Autodesk (NASDAQ:ADSK), Unity Software (NYSE:U), Datadog (NASDAQ:D Benzinga
- View Full Coverage on Google News